Chemical Structure (Lazcluze 01)
Lazcluze Tablet, Film Coated
Product Images NDC 57894-080
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lazcluze (NDC 57894-080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Janssen Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Lazcluze 02)
Principal Display Panel (240 mg Tablet Bottle Carton)
Principal Display Panel (80 mg Tablet Bottle Carton)
Recommended dosage for Tamperarsa is provided in this package. Each film-coated tablet contains 80 mg of lazertinib equivalent to 93.86 mg of lazertinib mesylate. This product is manufactured in Belgium. It is recommended to keep Tamperarsa at USP Controlled Room Temperature. Ensure to keep this product out of reach of children. For more information, refer to the Prescribing Information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
